AB
IRWD icon

Amalgamated Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Amalgamated Bank’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,027
Closed -$17K – 2221
2025
Q4 		$17K Buy
5,027
+350
+7% +$909 ﹤0.01% 2183
2025
Q3 		$6K Hold
4,677
– – ﹤0.01% 2678
2025
Q2 		$3K Hold
4,677
– – ﹤0.01% 2914
2025
Q1 		$7K Sell
4,677
-36,405
-89% -$86.7K ﹤0.01% 2527
2024
Q4 		$182K Sell
41,082
-375
-0.9% -$1.52K ﹤0.01% 1600
2024
Q3 		$171K Sell
41,457
-287
-0.7% -$1.54K ﹤0.01% 1611
2024
Q2 		$272K Sell
41,744
-1,465
-3% -$10.4K ﹤0.01% 1499
2024
Q1 		$376K Sell
43,209
-10,560
-20% -$128K ﹤0.01% 1417
2023
Q4 		$615K Sell
53,769
-3,834
-7% -$37.9K ﹤0.01% 1355
2023
Q3 		$555K Hold
57,603
– – ﹤0.01% 1356
2023
Q2 		$613K Sell
57,603
-3,897
-6% -$41.9K 0.01% 1335
2023
Q1 		$647K Sell
61,500
-4,161
-6% -$46.6K 0.01% 1309
2022
Q4 		$814K Hold
65,661
– – 0.01% 1230
2022
Q3 		$680K Sell
65,661
-6,032
-8% -$68.4K 0.01% 1274
2022
Q2 		$827K Buy
71,693
+47,757
+200% +$563K 0.01% 1214
2022
Q1 		$301K Sell
23,936
-1,815
-7% -$20.8K ﹤0.01% 1771
2021
Q4 		$300K Sell
25,751
-92
-0.4% -$1.13K ﹤0.01% 1816
2021
Q3 		$338K Sell
25,843
-1,591
-6% -$20.6K ﹤0.01% 1791
2021
Q2 		$353K Buy
27,434
+4,758
+21% +$54.5K ﹤0.01% 1806
2021
Q1 		$254K Sell
22,676
-2,258
-9% -$23.9K 0.01% 1351
2020
Q4 		$284K Buy
24,934
+129
+0.5% +$1.41K 0.01% 1257
2020
Q3 		$223K Sell
24,805
-715
-3% -$7.11K 0.01% 1270
2020
Q2 		$263K Sell
25,520
-2,036
-7% -$20.8K 0.01% 1183
2020
Q1 		$278K Sell
27,556
-323
-1% -$3.8K 0.01% 1184
2019
Q4 		$371K Buy
27,879
+597
+2% +$6.58K 0.01% 1286
2019
Q3 		$234K Sell
27,282
-405
-1% -$3.94K ﹤0.01% 1462
2019
Q2 		$303K Buy
27,687
+2,275
+9% +$25.5K 0.01% 1343
2019
Q1 		$288K Buy
25,412
+1,050
+4% +$11.7K 0.01% 1290
2018
Q4 		$211K Buy
+24,362
New +$280K 0.01% 1384
2018
Q3 		– Sell
-25,260
Closed -$405K – 1534
2018
Q2 		$405K Buy
25,260
+3,751
+17% +$55.5K 0.01% 1142
2018
Q1 		$278K Sell
21,509
-315
-1% -$3.93K 0.01% 1253
2017
Q4 		$274K Buy
21,824
+1,358
+7% +$17.7K 0.01% 1310
2017
Q3 		$270K Sell
20,466
-166
-0.8% -$2.28K 0.01% 1281
2017
Q2 		$326K Buy
20,632
+1,696
+9% +$24.6K 0.01% 1140
2017
Q1 		$271K Sell
18,936
-15
-0.1% -$205 0.01% 1202
2016
Q4 		$243K Buy
18,951
+2,611
+16% +$33K 0.01% 1274
2016
Q3 		$217K Buy
16,340
+20
+0.1% +$234 0.01% 1222
2016
Q2 		$182K Buy
16,320
+474
+3% +$4.63K 0.01% 1280
2016
Q1 		$145K Buy
15,846
+1,431
+10% +$11.8K 0.01% 1197
2015
Q4 		$140K Sell
14,415
-1,417
-9% -$13.7K 0.02% 1124
2015
Q3 		$138K Buy
15,832
+274
+2% +$2.56K 0.01% 1211
2015
Q2 		$157K Buy
15,558
+1,068
+7% +$12.4K 0.02% 1275
2015
Q1 		$194K Buy
14,490
+555
+4% +$7.28K 0.02% 885
2014
Q4 		$179K Buy
13,935
+18
+0.1% +$206 0.03% 812
2014
Q3 		$151K Sell
13,917
-5
-0% -$57 0.02% 803
2014
Q2 		$179K Buy
13,922
+873
+7% +$9.49K 0.03% 826
2014
Q1 		$135K Buy
+13,049
New +$147K 0.02% 792

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Amalgamated Bank's IRWD Position: Q1 2026 in Review

Amalgamated Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 5,027 shares — an estimated $17K sold.

Amalgamated Bank first reported a position in IRWD in Q1 2014 and held it in 47 quarters. The position peaked at $827K in Q2 2022. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Amalgamated Bank reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 5,027 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $17K.
  • Amalgamated Bank first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 47 quarters.
  • Amalgamated Bank's Ironwood Pharmaceuticals position peaked at $827K in Q2 2022.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.